Korro Bio, Inc. (KRRO) SEC Filings — 2024
28 SEC filings for Korro Bio, Inc. (KRRO) in 2024.
Filings
- Korro Bio Files 8-K — 8-K · Nov 21, 2024
- Korro Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Korro Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Korro Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Korro Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Korro Bio Files 10-Q: Updates on Operations and Novo Nordisk Deal — 10-Q · Nov 12, 2024
- Korro Bio Files 8-K — 8-K · Nov 4, 2024
- Korro Bio Enters Material Definitive Agreement — 8-K · Sep 16, 2024
- Korro Bio Appoints New CMO & CSO, Sees CMO Depart — 8-K · Aug 28, 2024
- Korro Bio Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Korro Bio, Inc. SC 13G/A Filing — SC 13G/A · Jul 12, 2024
- Korro Bio Appoints New CMO, Elects Director — 8-K · Jun 21, 2024
- Korro Bio, Inc. Files 8-K — 8-K · Jun 12, 2024
- Korro Bio, Inc. Files S-1 Registration Statement — S-1 · May 14, 2024
- Korro Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Korro Bio Files Proxy Statement — DEFA14A · May 1, 2024
- Korro Bio, Inc. Announces 2024 Annual Meeting of Stockholders on June 11 — DEF 14A · Apr 29, 2024
- Korro Bio, Inc. SC 13G Filing — SC 13G · Apr 26, 2024
- NEA 17 Amends Korro Bio Stake Filing — SC 13D/A · Apr 24, 2024
- Novartis to Acquire Korro Bio for Up to $855M — 8-K · Apr 22, 2024
- Korro Bio, Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Apr 18, 2024
- Korro Bio Files 8-K on Operations and Financials — 8-K · Mar 26, 2024
- Korro Bio, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
- Korro Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Korro Bio, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Korro Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- FMR LLC Discloses 9.088% Stake in Korro Bio, Inc. — SC 13G · Feb 9, 2024
- Korro Bio Files 8-K for Routine Administrative Update — 8-K · Jan 9, 2024